Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramyocardial bone marrow mononuclear cell therapy after acute myocardial infarction
2008-004625-42Phase 2Terminated
- Sponsor
- AskBio
- Start
- Aug 2008
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bone marrow mononuclear cells in myocardial infarction (MI), sponsored by AskBio. Primary endpoints: Left ventricular ejection fraction and Heart function by echocardiography. Started Aug 2008; status: terminated.
02
Drugs
bone marrow mononuclear cells
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2008-004625-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004625-42.